netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Thalidomide found 9 matches
Open monograph to display formulary status BNF Category
  Thalidomide Malignant disease and immunosuppression - Lenalidomide, pomalidomide, and thalidomide - 08.02.04
  Cytotoxic Drug Daratumumab  (Darzalex®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Letter sent to healthcare professionals in June 2016: Thalidomide Celgene®: New important advice regarding viral reactivation and pulmonary hypertension (08.02.04)
link in drug section MHRA Drug Safety Update (December 2015): Thalidomide: reduced starting dose in patients older than age 75 years (08.02.04)
link in drug section MHRA Drug Safety Update (July 2011): Thalidomide: risk of arterial and venous thromboembolism (08.02.04)
link in drug section MHRA Drug Safety Update (May 2013): Thalidomide: risk of second primary malignancies (08.02.04)
link in drug section NICE TA228: Bortezomib and thalidomide for the first‑line treatment of multiple myeloma (08.01.05)
link in drug section NICE TA228: Bortezomib and thalidomide for the first‑line treatment of multiple myeloma (08.02.04)

SubSection Titles / notes  
Lenalidomide, pomalidomide, and Thalidomide - (08.02.04)

 
netFormulary